Samantha McLemore - Patient Capital Management,
Holding/activity history for UBS AG (UBS)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 1,241,955 | 1.81 | Add 4.60% | 0.08 | $39.07 | $48,523,214 | SEC |
| 2025 Q4 | 1,187,326 | 2.12 | Reduce 20.89% | 0.51 | $46.31 | $54,985,061 | SEC |
| 2025 Q3 | 1,500,849 | 2.46 | Reduce 22.54% | 0.67 | $41.00 | $61,534,800 | SEC |
| 2025 Q2 | 1,937,639 | 2.96 | Reduce 5.16% | 0.17 | $33.82 | $65,530,949 | SEC |
| 2025 Q1 | 2,043,053 | 3.22 | Add 0.03% | <0.01 | $30.63 | $62,578,716 | SEC |
| 2024 Q4 | 2,042,420 | 2.86 | Add 1.01% | 0.03 | $30.32 | $61,926,182 | SEC |
| 2024 Q3 | 2,022,019 | 3.07 | Reduce 0.34% | 0.01 | $30.91 | $62,500,598 | SEC |
| 2024 Q2 | 2,028,937 | 3.18 | Reduce 13.29% | 0.47 | $29.54 | $59,934,794 | SEC |
| 2024 Q1 | 2,339,900 | 3.50 | Reduce 4.53% | 0.18 | $30.72 | $71,881,740 | SEC |
| 2023 Q4 | 2,450,937 | 4.02 | Reduce 1.28% | 0.05 | $30.90 | $75,733,966 | SEC |
| 2023 Q3 | 2,482,612 | 3.61 | Reduce 0.23% | <0.01 | $24.65 | $61,196,391 | SEC |
| 2023 Q2 | 2,488,265 | 2.81 | Add 1,016.82% | 2.56 | $20.27 | $50,437,133 | SEC |
| 2023 Q1 | 222,800 | 2.13 | Buy | 2.13 | $21.34 | $4,754,552 | SEC |